Bristol Myers Squibb (NYSE: BMY)
$60.39
(0.5%)
$0.31
Price as of March 20, 2025, 3:58 p.m. ET
Bristol Myers Squibb Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Bristol Myers Squibb Company Info
Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.
News & Analysis
The Fool has written over 500 articles on Bristol Myers Squibb.
Featured Article
Got $200? 2 Healthcare Stocks to Buy and Hold Forever
Prosper Junior Bakiny | Feb 26, 2025
Featured Article
Bristol Myers Squibb Tops Q4 Estimates
Bristol Myers Squibb reported strong fourth-quarter earnings but its outlook for 2025 failed to meet expectations.
JesterAI | Feb 6, 2025
2 High-Yield Dividend Stocks to Hold Through 2025 and Beyond
Prosper Junior Bakiny | Jan 31, 2025
3 Cheap Dividend Stocks That Pay More Than Double the S&P 500 Average
David Jagielski | Jan 29, 2025
This Unpopular Dividend Stock Is a Buy
George Budwell | Jan 9, 2025
2 High-Yield Dividend Stocks to Buy Early in 2025
George Budwell | Dec 31, 2024
Got $250? 2 Healthcare Stocks to Buy and Hold Forever
Prosper Junior Bakiny | Dec 19, 2024
These 2 Stocks Just Declared Dividend Raises That Kick In Next Year. Should You Buy?
Eric Volkman | Dec 19, 2024
Valuation
Podcast Episodes
The Top Biotech Stocks to Watch Following ASH 2019
The potential to reshape treatment of blood cancer and disorders could mean big bucks for these companies.
Todd Campbell | Dec 19, 2019
3 Biggest Stories at the J.P. Morgan Healthcare Conference This Year
These stocks skyrocketed following exciting announcements.
Todd Campbell | Jan 10, 2019
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.